ArticleMayo Clinic proceedings2026
A 5-Year Population-Based Study of Polymicrobial Enterococcal Bloodstream Infection in Southeast Minnesota.
Article in Mayo Clinic proceedings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo study the incidence, epidemiology and clinical outcome of polymicrobial enterococcal bloodstream (PE-BSI) infection in a geographically defined population of adults in the United States. PATIENTS AND
methodsAll adult (age ≥18 years) residents within 8 counties in southeast Minnesota who developed a first-ever episode of PE-BSI from January 1, 2018, through December 31, 2022, were identified using the Expanded Rochester Epidemiology Project (E-REP) medical records linkage system. Incidence rates were based on the number of cases divided by the person-years in the population.
resultsDuring the 5-year study period, 66 incident PE-BSI cases were observed (median age 71.3 years; 72.7% male), corresponding to an age- and sex-adjusted incidence rate of 4.1 cases per 100,000 person-years. Multivariable analysis showed that older age and male sex were associated with increased PE-BSI incidence (both P<.001). The most common source of bloodstream infection was non-urinary intra-abdominal (40.9%). Enterococcus faecalis was the most common bloodstream isolate (69.7%). Primary concomitant bloodstream organisms were Escherichia coli (18.2%), Staphylococcus aureus (15.2%), and coagulase-negative Staphylococcus (15.2%). Despite low rates of definite infective endocarditis (3.2%) and BSI relapse (3.0%), mortality rates following PE-BSI were relatively high (31.8% at 12 weeks, 47.3% at 1 year).
conclusionIn this population-based study of 66 incident PE-BSI cases, increased incidence was associated with older age and male sex. A non-urinary intra-abdominal source was most often detected and cumulative mortality rates were high.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.